Markus Hansson

Markus Hansson

UNVERIFIED PROFILE

Are you Markus Hansson?   Register this Author

Register author
Markus Hansson

Markus Hansson

Publications by authors named "Markus Hansson"

Are you Markus Hansson?   Register this Author

44Publications

590Reads

Bone marrow eosinophils in plasma cell disorders.

Exp Hematol 2018 Oct 5;66:27-31.e5. Epub 2018 Jul 5.

Department of Hematology, Skane University Hospital and Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.

View Article
October 2018

NOX2-dependent immunosuppression in chronic myelomonocytic leukemia.

J Leukoc Biol 2017 08 14;102(2):459-466. Epub 2017 Mar 14.

TIMM Laboratory, Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden; and

View Article
August 2017

Phagocyte function decreases after high-dose treatment with melphalan and autologous stem cell transplantation in patients with multiple myeloma.

Exp Hematol 2016 May 14;44(5):342-351.e5. Epub 2016 Jan 14.

Department of Hematology, Skåne University Hospital and Lund University, Lund, Sweden.

View Article
May 2016

Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in Sweden.

Acta Oncol 2016 May 17;55(5):554-60. Epub 2015 Nov 17.

b The Swedish Institute for Health Economics (IHE) , Lund , Sweden .

View Article
May 2016

Impaired phagocytosis and reactive oxygen species production in phagocytes is associated with systemic vasculitis.

Arthritis Res Ther 2016 Apr 22;18:92. Epub 2016 Apr 22.

Department of Clinical Sciences Lund, Nephrology, Lund University, Skane University Hospital, Lund, Sweden.

View Article
April 2016

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.

N Engl J Med 2016 Apr;374(17):1621-34

From University Hospital Hôtel Dieu, Nantes (P.M., C.T.), the Department of Hematology, Institut Paoli-Calmettes, Marseille (A.-M.S.), and the Department of Hematology and Cell Therapy, Hospital Saint Antoine, Paris (L.G.) - all in France; the Department of Haematology and Stem Cell Transplantation, St. István and St. László Hospital, 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary (T.M.); the Department of Haemato-oncology and Bone Marrow Transplantation, Medical University of Lublin, and St. John's Cancer Center, Lublin, Poland (N.G.); Southern Alberta Cancer Research Institute, University of Calgary, Calgary (N.J.B.), and the Division of Hematology, Department of Medicine, University of Alberta, Edmonton (I.S.) - both in Canada; the Department of Hematology, Skåne University Hospital, Lund University, Lund, Sweden (M.H.); Hematology and Oncology, University Hospital Brno, Brno, Czech Republic (L.P.); the Department of Haematology, Christchurch Hospital, Christchurch (P. Ganly), the Department of Haematology, Palmerston North Hospital, Palmerston North, Manawatu (B.W.B.), the Department of Haematology, Middlemore Hospital, Auckland (S.R.J.), and the Department of Haematology, North Shore Hospital, Auckland (D.R.S.) - all in New Zealand; the Department of Hematology, University Hospital Rigshospitalet, Copenhagen (P. Gimsing); Myeloma Unit, Division of Hematology, University of Turin, Turin (A.P.), and Seràgnoli Institute of Haematology, Bologna University School of Medicine, St. Orsola-Malpighi University Hospital, Bologna (M.C.) - both in Italy; the Division of Hematology, Mayo Clinic, Rochester, MN (S.K., F.K.B.); and Dana-Farber Cancer Institute, Boston (J.P.L., P.G.R.), and Millennium Pharmaceuticals, Cambridge (D.T.B., J.L., A.D.B., A.-M.H., H.V.) - both in Massachusetts.

View Article
April 2016

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma.

N Engl J Med 2015 Sep 26;373(13):1207-19. Epub 2015 Aug 26.

From the Department of Hematology, University Medical Center Utrecht, Utrecht (H.M.L., M.C.M., N.W.C.J.D.), and the Department of Hematology, VU University Medical Center, Amsterdam (H.M.L., N.W.C.J.D.) - both in the Netherlands; Vejle Hospital and University of Southern Denmark, Vejle (T.P., J.K.), and Rigshospitalet and University of Copenhagen (P.G., U.L.) and Genmab (N.L., S.L., L.B., N.B.), Copenhagen - all in Denmark; Dana-Farber Cancer Institute, Harvard Medical School, Boston (J.P.L., P.G.R.); Karolinska Institute and the Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Stockholm (H.N.), and Skåne University Hospital and Lund University, Lund (M.H.) - all in Sweden; Myeloma Unit, Division of Hematology, University of Turin, Turin, Italy (A.P.); Janssen Research and Development, Spring House, PA (T.A., C.M.U., A.K.S.); and Janssen Research and Development, Raritan, NJ (I.K., J.W.).

View Article
September 2015

Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.

Nat Commun 2015 May 26;6:7213. Epub 2015 May 26.

1] Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, BMC B13, SE-221 84 Lund, Sweden [2] Clinical Immunology and Transfusion Medicine, Laboratory Medicine, Office of Medical Services, Akutgatan 8, SE-221 85 Lund, Sweden [3] Broad Institute, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA.

View Article
May 2015

Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia.

Haematologica 2015 Jan 26;100(1):55-61. Epub 2014 Sep 26.

Division of Clinical Genetics, Department of Laboratory Medicine, Lund University

View Article
January 2015

Robust isolation of malignant plasma cells in multiple myeloma.

Blood 2014 Feb 2;123(9):1336-40. Epub 2014 Jan 2.

Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Sweden;

View Article
February 2014

Remission maintenance in acute myeloid leukemia: impact of functional histamine H2 receptors expressed by leukemic cells.

Haematologica 2012 Dec 11;97(12):1904-8. Epub 2012 Jun 11.

Department of Sahlgrenska Cancer Center, University of Gothenburg, Sweden.

View Article
December 2012

Neutrophil elastase and proteinase 3 trafficking routes in myelomonocytic cells.

Exp Cell Res 2010 Nov 7;316(19):3182-96. Epub 2010 Sep 7.

Department of Hematology, BMC C14, Lund University, SE-221 84 Lund, Sweden.

View Article
November 2010

The tetraspanin CD63 is involved in granule targeting of neutrophil elastase.

Blood 2008 Oct 31;112(8):3444-54. Epub 2008 Jul 31.

Department of Hematology, Lund University, Lund, Sweden.

View Article
October 2008

Biphenotypic bigenotypic lymphoma with simultaneous expression of PAX5/BSAP and B- and T-cell markers.

Eur J Haematol 2007 Aug;79(2):159-65

Department of Hematology, Lund University Hospital, Lund, Sweden.

View Article
August 2007

Neutrophil elastase sorting involves plasma membrane trafficking requiring the C-terminal propeptide.

Exp Cell Res 2006 Nov 26;312(18):3471-84. Epub 2006 Jul 26.

Department of Clinical Sciences, Section for Clinical and Experimental Infection Medicine, B14, BMC, SE-221 84 Lund, Sweden.

View Article
November 2006

Biosynthesis, processing, and sorting of human myeloperoxidase.

Arch Biochem Biophys 2006 Jan 31;445(2):214-24. Epub 2005 Aug 31.

Department of Hematology, C14, BMC, SE-221 84 Lund, Sweden.

View Article
January 2006

Reactivation of latent Epstein Barr virus infection induces remission of splenic lymphoma with villous lymphocytes.

Int J Hematol 2005 Jun;81(5):413-6

Department of Hematology, C14, BMC, Lund University Hospital, SE-221 84 Lund, Sweden.

View Article
June 2005

Activation of cytotoxic lymphocytes by interferon-alpha: role of oxygen radical-producing mononuclear phagocytes.

J Leukoc Biol 2004 Dec 10;76(6):1207-13. Epub 2004 Sep 10.

Department of Hematology, University of Lund, Sweden.

View Article
December 2004

Sorting soluble tumor necrosis factor (TNF) receptor for storage and regulated secretion in hematopoietic cells.

J Leukoc Biol 2004 Oct 7;76(4):876-85. Epub 2004 Jul 7.

Department of Hematology, C14, BMC, Lund, Sweden.

View Article
October 2004

Biosynthesis and sorting of myeloperoxidase in hematopoietic cells.

Jpn J Infect Dis 2004 Oct;57(5):S13-4

Department of Hematology, Lund University, Lund, Sweden.

View Article
October 2004